SCI时时刷

search
+
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options
Pityriasis rubra pilaris (PRP) is a rare papulosquamous reaction pattern with a significant impact on quality of life. Typ...
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
The ALLEGRO phase 2a and 2b/3 studies demonstrated that ritlecitinib, an oral JAK3/TEC family kinase inhibitor, is efficac...
Mucocutaneous Manifestations of Recreational Drug Use
Mucocutaneous Manifestations of Recreational Drug Use
Recreational drug use is increasingly common in the dermatology patient population and is often associated with both gener...
The Skin Microbiome and its Significance for Dermatologists
The Skin Microbiome and its Significance for Dermatologists
The skin is a physical and immunological barrier to the external environment. Its large surface area is colonized by diver...
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure
Skin perceives and reacts to external mechanical forces to create resistance against the external environment. Excessive o...
Recent Advances in Treatment of Systemic Sclerosis and Morphea
Recent Advances in Treatment of Systemic Sclerosis and Morphea
Systemic sclerosis (SSc) and morphea are autoimmune sclerosing diseases that cause significant morbidity, and in the case ...
Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis
Small-Molecule Inhibitors and Biologics for Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta-Analysis
The comparative efficacy of biologics and small-molecule inhibitors in treating palmoplantar psoriasis (PP) and palmoplant...
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance
Dermatophytoses are fungal infections of the skin, hair, and nails that affect approximately 25% of the global population....
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Atopic dermatitis is a chronic inflammatory disease characterized by increased itch, skin pain, poor sleep quality, and ot...
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses
Secondary bacterial infections of common dermatoses such as atopic dermatitis, ectoparasitosis, and varicella zoster virus...
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis
Ultrasound surveillance has become the new standard of care in stage III melanoma after the 2017 Multicenter Selective Lym...
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates
Merkel cell carcinoma (MCC) is a rare skin cancer characterized by neuroendocrine differentiation. Its carcinogenesis is b...
Treat-to-Target in Atopic Dermatitis
Treat-to-Target in Atopic Dermatitis
Atopic dermatitis is one of the most common inflammatory skin diseases among children and adults. Over the last 5 years, t...
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Review of Teledermatology: Lessons Learned from the COVID-19 Pandemic
Utilization of telemedicine for dermatology has greatly expanded since the start of the COVID-19 pandemic, with over 500 n...
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy
Basal cell carcinoma (BCC) is the most common skin cancer, for which there are multiple treatment options, including the g...
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International ...
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus
Cutaneous T-cell lymphomas are a heterogenous group of lymphomas that cause various skin manifestations. Severe pruritus o...
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives
Hormonal and immunologic changes during pregnancy can contribute to the development of different dermatoses, the most comm...
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Dermatology Section, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyLuca Stingeni, Rossella Mari...
Non-invasive Skin Imaging in Cutaneous Lymphomas
Non-invasive Skin Imaging in Cutaneous Lymphomas
The diagnosis of cutaneous lymphomas is challenging and requires skin tissue for histology and immunophenotyping using imm...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Investigator’s Global Assessment of clear/almost clear skin (IGA 0/1) is a difficult endpoint to achieve after short...
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Treatment of moderate-to-severe plaque psoriasis with biologics, such as guselkumab, has demonstrated greater efficacy ove...
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Chronic prurigo (CPG) is a neuroinflammatory, fibrotic dermatosis that is defined by the presence of chronic pruritus (itc...
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
AtopyReg® is a multicenter, prospective, observational, non-profit cohort study on moderate-to-severe atopic dermatit...
Oral Lichen Planus: An Update on Diagnosis and Management
Oral Lichen Planus: An Update on Diagnosis and Management
Oral lichen planus (OLP) is a chronic inflammatory disease whose pathogenesis involves a T-cell mediated, epithelium-direc...
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Atopic dermatitis (AD) is a chronic inflammatory disease requiring efficacious and safe long-term therapy. Several new sys...
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Infammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
Department of Pharmacy, Chang Gung Memorial Hospital, Linkou, Taoyuan, TaiwanChia-Ling Yu & Li-Huei ChiangDepartment o...
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Two phase III trials, ECZTRA 1 and 2, confirmed the efficacy and safety of tralokinumab versus placebo in adults with mode...
阅读更多
format_indent_increase